El péptido natriurético Dendroaspis: endógeno o dudoso?

Plasma Proteomic Signatures of Left Atrial Dysfunction and Cerebral Small Vessel Disease: Elucidating Heart-Brain Connections.

JACC. Basic to translational science·2026

Toll-like receptor 7 constrains efferocytosis in myocardial injury.

Basic research in cardiology·2026

Soluble urokinase plasminogen activator receptor for risk stratification from undifferentiated acute chest pain through to convalescence after acute coronary syndromes.

European heart journal open·2026

Treatment of OSA using mandibular advancement versus CPAP in improving cardiovascular health.

The American journal of medicine·2026

Association of Left Ventricular Function With Cerebral Small Vessel Disease and Cognition.

Journal of the American Heart Association·2026

Myocardial Infarction Without Standard Modifiable Risk Factors From 2025-2040: Forecast Analysis of Multinational, Population-Based Study.

JACC. Asia·2026

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Wanting this, not that: The neural circuit that turns specific expectations into actions.

PLoS biology·2026

Synaptic dysfunction as a major driver in Alzheimer's disease: Beyond the amyloid paradigm.

Neuroscience and biobehavioral reviews·2026

Frustrative non-reward: A cross-species probe to study brain mechanisms of irritability.

Translational psychiatry·2026

The ontological status of behaviour: lessons from experimental neurosis (1900-1950).

History and philosophy of the life sciences·2026

No association between delayed graft function and BK polyomavirus infection reactivation after kidney transplantation: a systematic review and meta-analysis.

Frontiers in nephrology·2026

Characterization of behaviors during food consumption under novelty and threat learning in male and female rats.

Behavioral neuroscience·2026

Videos de Experimentos Relacionados

El péptido natriurético Dendroaspis: endógeno o dudoso?

Videos de Conceptos Relacionados

Plasma Proteomic Signatures of Left Atrial Dysfunction and Cerebral Small Vessel Disease: Elucidating Heart-Brain Connections.

Toll-like receptor 7 constrains efferocytosis in myocardial injury.

Soluble urokinase plasminogen activator receptor for risk stratification from undifferentiated acute chest pain through to convalescence after acute coronary syndromes.

Treatment of OSA using mandibular advancement versus CPAP in improving cardiovascular health.

Association of Left Ventricular Function With Cerebral Small Vessel Disease and Cognition.

Myocardial Infarction Without Standard Modifiable Risk Factors From 2025-2040: Forecast Analysis of Multinational, Population-Based Study.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Wanting this, not that: The neural circuit that turns specific expectations into actions.

Synaptic dysfunction as a major driver in Alzheimer's disease: Beyond the amyloid paradigm.

Frustrative non-reward: A cross-species probe to study brain mechanisms of irritability.

The ontological status of behaviour: lessons from experimental neurosis (1900-1950).

No association between delayed graft function and BK polyomavirus infection reactivation after kidney transplantation: a systematic review and meta-analysis.

Characterization of behaviors during food consumption under novelty and threat learning in male and female rats.

Videos de Experimentos Relacionados

El péptido natriurético Dendroaspis: endógeno o dudoso?

Videos de Conceptos Relacionados

Artículos Relacionados